Publications by authors named "Dora Ferrari"

Claim this Profile
Q
Quantifying survival in patients with Proteus syndrome.
Julie C Sapp, Lian Hu, Jean Zhao, Ashlyn Gruber, Brian Schwartz, Dora Ferrari

Genet Med· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repression of AKT signaling by ARQ 092 in cells and tissues from patients with Proteus syndrome.
Marjorie J Lindhurst, Miranda R Yourick, Yi Yu, Ronald E Savage, Dora Ferrari

Sci Rep· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 dose-escalation trial evaluating the combination of the selective MET (mesenchymal-epithelial transition factor) inhibitor tivantinib (ARQ 197) plus erlotinib.
Jonathan W Goldman, Isett Laux, Feng Chai, Ronald E Savage, Dora Ferrari

Cancer· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancer.
Lecia V Sequist, Joachim von Pawel, Edward G Garmey, Wallace L Akerley, Wolfram Brugger, Dora Ferrari

J Clin Oncol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis